John Bermingham, DO
Pulmonary Disease · Marlton, NJNPI 1700847910
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 249 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,039 and has fallen 77.3% since, to $236 in 2025.
Across 249 payments — averaging $14.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$748
- AstraZeneca$730
- Boehringer Ingelheim$272
- Grifols USA, LLC$251
- Philips North America LLC$214
- United Therapeutics Corporation$192
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,660100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 72 | $748 |
| AstraZeneca | 44 | $730 |
| Boehringer Ingelheim | 20 | $272 |
| Grifols USA, LLC | 17 | $251 |
| Philips North America LLC | 14 | $214 |
| United Therapeutics Corporation | 3 | $192 |
| Amgen | 8 | $156 |
| Mylan Specialty L.p. | 10 | $142 |
| Regeneron Healthcare Solutions, Inc. | 8 | $114 |
| Sanofi | 6 | $94 |
| Sunovion Pharmaceuticals Inc. | 5 | $75 |
| Novartis | 4 | $65 |
| Electromed, Inc. | 7 | $63 |
| Jazz Pharmaceuticals Inc. | 4 | $62 |
| Insmed, Inc. | 4 | $59 |
| Viatris Specialty LLC | 1 | $59 |
| Teva Pharmaceuticals USA, Inc. | 4 | $55 |
| Advanced Respiratory, Inc | 2 | $53 |
| Baxter Healthcare | 1 | $41 |
| Actelion Pharmaceuticals US, Inc. | 2 | $29 |
| Bayer | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $24 |
| Merck | 2 | $23 |
| Resmed Corp | 1 | $20 |
| Pulmonx Corporation | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
| Harmony Biosciences LLC | 1 | $13 |
| Eisai Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TYVASO$157
How this compares
$3,660 in reported general payments places this provider in the 60th percentile of 472 pulmonary disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $480 |
| Montelukast Sodium | 13 | $288 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Marlton
- Heather GianniniMarlton$22K
- Thomas NugentMarlton$18K
- Joseph HoffmanPark Ridge$1.1M
- Reynold PanettieriNew Brunswick$1M
- Robert SussmanSummit$551K
- Manuel CunananMillville$489K
- Emanuele SantomauroHackensack$420K
- Richard MillerNewark$328K
- Jason ShatkinParamus$282K
- Anthony RickettiTrenton$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.